Literature DB >> 22358660

Evaluation of a simple protein free medium that supports high levels of monoclonal antibody production.

Y M Qi1, P F Greenfield, S Reid.   

Abstract

A simple protein free medium was formulated and tested in suspension culture using three hybridoma cell lines. The medium, referred to as CDSS (Chemically Defined Serum Substitutes), consisted of the basal medium DMEM:Ham F12, 1:1, with HEPES (D12H), plus pluronic F68, trace elements, ferric citrate, ascorbic acid, and ethanolamine. No protein or lipid components were added. All three cell lines were weaned off serum using CDSS and a commercially available protein free medium PFHM-II. Data shown here indicated that normally cells took 1-7 weeks to wean off serum and an additional 2-7 weeks to adapt to suspension culture. After adaptation the cells were able to grow well in suspension culture using both protein free media and in the main performed better than serum containing controls. The stability of the three hybridoma cells for antibody production following freeze/thaw procedures and long term subculturing was also tested. All three lines were frozen using our protein free CDSS medium (containing 0.75% bovine serum albumin and 10% dimethyl sulfoxide) in liquid nitrogen for up to one year. Cells thawed from these stocks recovered well and were able to maintain good growth and antibody production characteristics. One line was shown to grow using our protein free CDSS medium in suspension culture for 12 weeks without loss of antibody productivity.

Entities:  

Year:  1996        PMID: 22358660     DOI: 10.1007/BF02215660

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  19 in total

1.  Weaning of three hybridoma cell lines to serum free low protein medium.

Authors:  K Radford; W Niloperbowo; S Reid; P F Greenfield
Journal:  Cytotechnology       Date:  1991-05       Impact factor: 2.058

Review 2.  Serum-free medium for fermentor cultures of hybridomas.

Authors:  O W Merten; J Litwin
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

Review 3.  Nutrient optimization for high density biological production applications.

Authors:  D W Jayme
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

4.  A kinetic analysis of hybridoma growth and metabolism in continuous suspension culture on serum-free medium.

Authors:  G W Hiller; A D Aeschlimann; D S Clark; H W Blanch
Journal:  Biotechnol Bioeng       Date:  1991-10-05       Impact factor: 4.530

5.  Serum-free media in hybridoma culture and monoclonal antibody production.

Authors:  M C Glassy; J P Tharakan; P C Chau
Journal:  Biotechnol Bioeng       Date:  1988-10-05       Impact factor: 4.530

6.  Loss of antibody productivity during long-term cultivation of a hybridoma cell line in low serum and serum-free media.

Authors:  S S Ozturk; B O Palsson
Journal:  Hybridoma       Date:  1990-04

7.  A serum-free medium for hybridoma cell culture.

Authors:  Z Chen; Y Ke; Y Chen
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

8.  Effects of dissolved oxygen concentration on hybridoma growth and metabolism in continuous culture.

Authors:  W M Miller; C R Wilke; H W Blanch
Journal:  J Cell Physiol       Date:  1987-09       Impact factor: 6.384

9.  Optimisation of hybridoma cell growth and monoclonal antibody secretion in a chemically defined, serum- and protein-free culture medium.

Authors:  Y J Schneider
Journal:  J Immunol Methods       Date:  1989-01-06       Impact factor: 2.303

10.  Measurement of the concentration of murine IgG monoclonal antibody in hybridoma supernatants and ascites in absolute units by sensitive and reliable enzyme-linked immunosorbent assays (ELISA).

Authors:  J O Fleming; L B Pen
Journal:  J Immunol Methods       Date:  1988-05-25       Impact factor: 2.303

View more
  1 in total

1.  Adaptation of mammalian cells to growth in serum-free media.

Authors:  M S Sinacore; D Drapeau; S R Adamson
Journal:  Mol Biotechnol       Date:  2000-07       Impact factor: 2.695

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.